首页> 外文期刊>Journal of the American Society of Nephrology: JASN >Serum Phosphate: A Novel Cardiovascular Risk Factor Even in Nonrenal Patients Relation between Serum Phosphate Level and Cardiovascular Event Rate in People with Coronary Disease. Circulation 112: 2627-2633, 2005
【24h】

Serum Phosphate: A Novel Cardiovascular Risk Factor Even in Nonrenal Patients Relation between Serum Phosphate Level and Cardiovascular Event Rate in People with Coronary Disease. Circulation 112: 2627-2633, 2005

机译:血清磷酸盐:即使在非肾病患者中,心血管疾病的新危险因素也与冠心病患者血清磷酸盐水平和心血管事件发生率之间的关系有关。发行112:2627-2633,2005

获取原文
       

摘要

It has been known for decades that hyperphosphatemia is a feature of ESRD that may cause secondary hyperparathyroidism and soft tissue calcification (1), including vascular calcification (2). The latter comprises mainly calcification of intimal plaques (3) and of the media (4,5) of central arteries (M??nckeberg sclerosis), less frequently calcification of muscular arteries (the only type of vascular calcification that potentially disappears after reversal of hyperparathyroidism [6]) and calcific uremic arteriolopathy (calciphylaxis) (7,8).
机译:数十年来,已知高磷酸盐血症是ESRD的特征,可引起继发性甲状旁腺功能亢进和软组织钙化(1),包括血管钙化(2)。后者主要包括内膜斑块(3)和中央动脉(M ?? nckeberg硬化)的中层钙化(4,5)钙化,而肌肉动脉钙化的频率则较低(唯一一种在血管内膜反转后可能消失的血管钙化类型)甲状旁腺功能亢进[6])和尿路上的钙化尿毒症(钙减少症)[7,8]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号